Pr Hazum - Painreform CTO Director
| PRFX Stock | USD 2.97 0.23 7.19% |
Insider
Pr Hazum is CTO Director of Painreform
| Address | 65 Yigal Alon St., Tel Aviv, Israel, 6744316 |
| Phone | 972 3 7177050 |
| Web | https://www.painreform.com |
Painreform Management Efficiency
The company has return on total asset (ROA) of (1.9507) % which means that it has lost $1.9507 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (7.1667) %, meaning that it created substantial loss on money invested by shareholders. Painreform's management efficiency ratios could be used to measure how well Painreform manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.99 in 2024. Return On Capital Employed is likely to drop to -1.34 in 2024. At this time, Painreform's Net Tangible Assets are fairly stable compared to the past year. Total Assets is likely to rise to about 11.1 M in 2024, whereas Other Current Assets are likely to drop slightly above 1.3 M in 2024.Similar Executives
| Showing other executives | INSIDER Age | ||
| YatGai Au | Regencell Bioscience Holdings | 51 | |
| Melissa Angelini | Procaps Group SA | N/A | |
| Rami Levy | INC Research Holdings | 59 | |
| Baochang Liu | Universe Pharmaceuticals | 44 | |
| Lin Yang | Universe Pharmaceuticals | 48 | |
| Javier Franco | Flora Growth Corp | 56 | |
| James Choe | Flora Growth Corp | 45 | |
| Matthew Cohen | Flora Growth Corp | 58 | |
| CPA CPA | Flora Growth Corp | N/A | |
| Luis Merchan | Flora Growth Corp | 43 | |
| FCA FCA | Flora Growth Corp | 79 | |
| Gang Lai | Universe Pharmaceuticals | 56 | |
| Michelle Chan | Regencell Bioscience Holdings | N/A | |
| Jessie Casner | Flora Growth Corp | 36 | |
| Wai Chung | Regencell Bioscience Holdings | 47 | |
| Advocate Ohayon | INC Research Holdings | 35 | |
| Patricio Munoz | Procaps Group SA | 51 | |
| OriMoni Mimon | INC Research Holdings | 36 | |
| Amos Cohen | INC Research Holdings | 45 | |
Management Performance
| Return On Equity | -7.17 | ||||
| Return On Asset | -1.95 |
Painreform Leadership Team
Elected by the shareholders, the Painreform's board of directors comprises two types of representatives: Painreform inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Painreform. The board's role is to monitor Painreform's management team and ensure that shareholders' interests are well served. Painreform's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Painreform's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Sigal Aviel, Chief Officer | ||
| Ilan MBA, CEO CFO | ||
| Rita Keynan, Vice Operations | ||
| MBA MBA, CEO CFO | ||
| Ehud Geller, Executive Chairman | ||
| Pr Hazum, CTO Director | ||
| Stephen DMD, Executive Development |
Painreform Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Painreform a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -7.17 | ||||
| Return On Asset | -1.95 | ||||
| Current Valuation | (942.84 K) | ||||
| Shares Outstanding | 556.61 K | ||||
| Shares Owned By Insiders | 3.50 % | ||||
| Shares Owned By Institutions | 5.08 % | ||||
| Number Of Shares Shorted | 121.08 K | ||||
| Price To Book | 0.63 X | ||||
| EBITDA | (9.57 M) | ||||
| Net Income | (9.34 M) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Painreform Stock Analysis
When running Painreform's price analysis, check to measure Painreform's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Painreform is operating at the current time. Most of Painreform's value examination focuses on studying past and present price action to predict the probability of Painreform's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Painreform's price. Additionally, you may evaluate how the addition of Painreform to your portfolios can decrease your overall portfolio volatility.